FTC and seven states sue telehealth firm Hims over health data privacy

The FTC has added five more states to its lawsuit against Hims & Hers, expanding claims over alleged health data sharing, recurring billing, and cancellation hurdles. The case could shape how telehealth companies handle patient privacy disclosures and subscription practices.

FTC and seven states sue telehealth firm Hims over health data privacy
Type
Child
Status
Approved
Title (YouTube)
Images Failed (Social)
Do not index
Publish Date (TikTok)
Videos Post IDs (Social)
Hashtags (Social)
Caption
Caption X
Cover
hims-health-data-privacy-telehealth-lawsuit.png
OG Image
hims-health-data-privacy-telehealth-lawsuit.png
Alt Image Text
Flat vector illustration of a telehealth lawsuit over Hims health data privacy, showing a patient using online care while medical data flows to third parties, with a cracked shield, billing symbols, and a gavel representing telehealth lawsuit scrutiny.
Images
Videos
Publish Date (Social)
Scheduled (Social)
Images Posted (Social)
Videos Posted (Social)
Featured
Created time
Nov 11, 2026 12:43 AM
Sub-item
Authors
CTA Practice Area (Social)
TikTok Failed (Social)
Videos Post Links (Social)
TikTok Post Links (Social)
Images Post IDs (Social)
YT Post ID
Video Pending Manual (Social)
TikTok Posted (Social)
TikTok Post IDs (Social)
Video Cover (Social)
Images Post Links (Social)
First Comment (Social)
Videos Failed (Social)
YT Embedded
Images Delete (Social)
Videos Delete (Social)
Carousel Video URL (Social)
The Federal Trade Commission has expanded its case against Hims & Hers, filing an amended lawsuit on November 10, 2026 in the U.S. District Court for the Northern District of California and adding Arizona, Florida, Nebraska, Ohio, and Wisconsin as co-plaintiffs alongside California and Utah. According to the FTC, the telehealth company allegedly shared sensitive patient health information with advertising platforms while presenting its services as private, and also used billing and cancellation practices that regulators describe as deceptive and unlawful in the amended complaint.
The agency’s latest filing broadens a case first announced on July 29, 2026, when federal and state regulators accused Hims of charging patients for prescriptions almost immediately after online intake, enrolling consumers into recurring subscriptions, and making cancellations difficult, according to the original federal complaint. Reuters also reported that five additional states joined the suit this week, underscoring how closely regulators are watching digital health companies’ handling of medical data and recurring charges, as described in the FTC’s November 10 enforcement announcement.

Background On The Case

At the center of the lawsuit is a familiar promise in telehealth marketing: convenience, speed, and privacy. Hims markets online treatment options for sensitive conditions, and regulators say that privacy-focused messaging mattered because users were being asked to disclose information about medical conditions before receiving treatment. In the July 29 case announcement, the FTC alleged that Hims shared consumers’ health information with Meta, Snap, and other third parties despite representing that the service would protect patient privacy.
The complaint also goes beyond privacy. Regulators allege that many consumers were led to believe they could submit an intake form, consult with a provider, and decide whether a treatment was right for them before any charge occurred. Instead, the FTC says, many users were billed and enrolled into subscription treatment plans shortly after submitting intake information, a theory laid out in the lawsuit’s summary of the case. The agency further alleges that Hims’ cancellation process was difficult to navigate, including claims that online cancellation options were buried behind multiple steps.
That combination matters. A privacy case by itself can draw serious scrutiny. A privacy case paired with alleged subscription traps and recurring billing concerns can become a broader consumer-protection test case, particularly when it involves health information and online treatment services.

The Legal Framework Behind The Lawsuit

The FTC says the conduct violates Section 5 of the FTC Act, which bars unfair or deceptive acts or practices, along with the Restore Online Shoppers’ Confidence Act, often called ROSCA. In general terms, ROSCA is designed to address online negative-option and recurring-charge practices by requiring clear disclosures, express informed consent, and simple cancellation mechanisms, as outlined in the statute’s FTC summary.
The amended complaint also adds claims under the consumer-protection laws of Arizona, Florida, Nebraska, Ohio, and Wisconsin, on top of the California and Utah claims already in the case, according to the FTC’s announcement of the newly added state plaintiffs. That wider coalition may matter for two reasons: it increases the geographic scope of the litigation, and it suggests that state attorneys general and consumer agencies are treating telehealth privacy and billing practices as a shared enforcement priority rather than a one-off dispute.
For consumers, one of the most important features of this case is that it sits at the intersection of health privacy, ad-tech tracking, automatic renewals, and online disclosures. Those issues have surfaced repeatedly across the broader digital economy, but telehealth raises the stakes because the underlying data can reveal intimate medical concerns, treatment interests, or prescription activity.

Why The Added States Matter

The addition of five more states is more than a procedural update. It signals a broader enforcement pattern: regulators appear increasingly willing to treat telehealth platforms like other subscription-based digital businesses when it comes to cancellation flows, dark patterns, and express consent, while also treating health-related data sharing as uniquely sensitive.
In practical terms, multistate participation may expand the remedies being sought and increase litigation pressure. The original complaint sought permanent injunctive relief, monetary relief, and civil penalties under federal and state law, as described in the filing’s request for relief. When several states align with the FTC in a consumer case, companies often face a more complicated defense environment because they are answering not only federal deception theories but also multiple state-law claims.
This may also resonate outside Hims itself. Other telehealth platforms, wellness apps, online pharmacies, and digital care startups may be watching closely, especially if they rely on tracking pixels, customer lists, retargeting tools, or subscription funnels. Even if a company views those tools as ordinary marketing infrastructure, regulators may view them differently when the underlying information can identify or strongly suggest a person’s medical condition or treatment interest.

What The Allegations May Mean For Consumers

For people who use telehealth services, the case highlights two recurring questions: Where does my health information go after I enter it? And When exactly am I agreeing to be charged?
The FTC’s allegations suggest that privacy language on a website may not tell the whole story if third-party trackers, ad pixels, or uploaded customer lists are operating in the background. Likewise, checkout and intake flows can create confusion when billing information is collected early but consumers believe a medical review or consultation will happen before any paid enrollment begins.
Some consumers in similar situations may want to consider looking closely at intake screens, recurring billing disclosures, refill timing, cancellation steps, and privacy representations. An attorney might help determine whether a telehealth company’s disclosures matched its actual practices, particularly where recurring charges, medical privacy concerns, or state consumer laws are involved.
For businesses, the lawsuit may become an important marker for how regulators evaluate the line between marketing analytics and unlawful data sharing in health-related settings. It may also shape expectations around how clearly a company presents subscription terms before charging a user.

What Comes Next

At this stage, these are allegations, not findings. The FTC itself notes that it files a complaint when it has “reason to believe” the law may have been violated and that the case will be decided by the court. That distinction matters, especially in fast-moving enforcement actions where the public narrative can outpace the litigation record.
Still, the expanded case is a noteworthy legal development. It combines one of the most sensitive categories of consumer data—health information—with one of the most litigated areas of e-commerce enforcement—recurring subscription billing. If regulators prevail on some or all of their theories, the case could influence how telehealth companies design consent flows, cancellation tools, ad tracking practices, and privacy messaging going forward.
For patients, subscribers, and investors, the broader takeaway is that telehealth is no longer being treated as a lightly regulated corner of the internet. It is increasingly being treated as a high-scrutiny sector where privacy promises, payment practices, and interface design may all carry legal consequences.
If you're facing legal challenges, ReferU.AI analyzes billions of court records to match you with attorneys who've successfully represented cases just like yours.